Search Results

You are looking at 1 - 10 of 145 items for :

  • differentiated thyroid carcinoma x
  • Refine by Access: All content x
Clear All
Open access

S C Clement, W E Visser, C A Lebbink, D Albano, H L Claahsen-van der Grinten, A Czarniecka, R P Dias, M P Dierselhuis, I Dzivite-Krisane, R Elisei, A Garcia-Burillo, L Izatt, C Kanaka-Gantenbein, H Krude, L Lamartina, K Lorenz, M Luster, R Navardauskaitė, M Negre Busó, K Newbold, R P Peeters, G Pellegriti, A Piccardo, A L Priego, A Redlich, L de Sanctis, M Sobrinho-Simões, A S P van Trotsenburg, F A Verburg, M Vriens, T P Links, S F Ahmed, and H M van Santen

Background Pediatric differentiated thyroid carcinoma (DTC) is a rare disease, although it is the most frequent endocrine malignancy in children, representing 2–4% of all pediatric malignancies. According to the Surveillance, Epidemiology, and

Open access

Alexander Heinzel, Dirk Müller, Hanneke M van Santen, Sarah C Clement, Arthur B Schneider, and Frederik A Verburg

-1375678 ) 13 Thies ED Tanase K Maeder U Luster M Buck AK Hanscheid H Reiners C Verburg FA . The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma

Open access

Simonetta Piana, Eleonora Zanetti, Alessandra Bisagni, Alessia Ciarrocchi, Davide Giordano, Federica Torricelli, Teresa Rossi, and Moira Ragazzi

mediates growth suppression by cell cycle arrest in well-differentiated thyroid carcinomas (WDTCs) ( 15 , 16 ). On the other side, NOTCH1 has been described highly expressed in WDTC with BRAF , RET /papillary thyroid carcinoma (PTC) mutation or active

Open access

Meihua Jin, Woo Kyung Lee, Mi-Hyeon You, Ahreum Jang, Sheue-yann Cheng, Won Gu Kim, Min Ji Jeon, and Yu-Mi Lee

, anaplastic thyroid carcinoma. SHMT2 is associated with de-differentiation and stemness of thyroid cancer To validate the clinical importance of the SHMT2 in human thyroid cancer, we performed a comprehensive analysis using transcriptomes and

Open access

David C Llewellyn, Rajaventhan Srirajaskanthan, Royce P Vincent, Catherine Guy, Eftychia E Drakou, Simon J B Aylwin, Ashley B Grossman, John K Ramage, and Georgios K Dimitriadis

, Napsin A, thyroglobulin and p40 was negative ( Fig. 4C ). The Ki-67 proliferation index was high at 84%. The morphology and immunophenotype were most in keeping with metastatic medullary thyroid carcinoma, although other metastatic neuroendocrine

Open access

Olav Inge Håskjold, Henrik Stenestø Foshaug, Therese Benedikte Iversen, Helga Charlotte Kjøren, and Vegard Heimly Brun

: colloid nodule, adenomatoid colloid nodule, follicular adenoma, follicular carcinoma, follicular variant of papillary thyroid carcinoma, papillary thyroid carcinoma, or other thyroid cancer. The operator also indicated the confidence of the assignment to

Open access

Tiemo S Gerber, Arno Schad, Nils Hartmann, Erik Springer, Ulrich Zechner, and Thomas J Musholt

Introduction Poorly differentiated thyroid carcinoma (PDTC) represents an aggressive variant of thyroid cancer that predominantly arises from the differentiated variants of papillary and follicular thyroid carcinoma (PTC and FTC, respectively

Open access

Luchuan Li, Baoyuan Li, Bin Lv, Weili Liang, Binbin Zhang, Qingdong Zeng, Andrew G Turner, and Lei Sheng

, all were assessed to be well-differentiated papillary thyroid carcinoma (PTC), namely 21 cases (81%) of papillary thyroid microcarcinoma (PTMC), 3 cases (12%) of conventional PTC, and 2 cases (7%) of a tall-cell variant of PTC ( Table 3 ). Bilaterality

Open access

Andrea Mazurat, Andrea Torroni, Jane Hendrickson-Rebizant, Harbinder Benning, Richard W Nason, and K Alok Pathak

Introduction Well-differentiated thyroid carcinoma (WDTC) represents a group of thyroid cancers that are associated with increasing incidence and excellent posttreatment outcome (1) . This group comprises different histological types, the most

Open access

Flávia O Valentim, Bárbara P Coelho, Hélio A Miot, Caroline Y Hayashi, Danilo T A Jaune, Cristiano C Oliveira, Mariângela E A Marques, José Vicente Tagliarini, Emanuel C Castilho, Paula Soares, and Gláucia M F S Mazeto

Introduction The differential diagnosis of thyroid follicular lesions includes both benign tumors, such as follicular adenoma (FA) and malignant tumors, such as follicular carcinoma (FC) and follicular variant of papillary carcinoma (FVPC